CompanyGraph
DocMorris AG
DOCM · SIX Swiss · Switzerland
corporate.docmorris.comFinancials as of FY2024 · latest on file
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- ScaleRevenue is $1.44B, above the global median of $558.46M
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
591.89MCHF721.91M · vs all stocks (USD)
Revenue (TTM)
1.18BCHF1.44B · vs all stocks (USD)
Profit Margin
-10.65%vs Pharmaceutical Retailers peers
Beta
1.88xvs all stocks
52-Week Change
94.96%vs all stocks
Market Capitalization
591.89MCHF721.91M · vs all stocks (USD)
Enterprise Value
703.78MCHF858.37M · vs all stocks (USD)
Forward P/E
-11.98xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
0.4821xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
1.51xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.5950xvs Pharmaceutical Retailers peers
Enterprise to EBITDA
-9.31xvs Pharmaceutical Retailers peers
Profit Margin
-10.65%vs Pharmaceutical Retailers peers
Operating Margin
-6.83%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
-6.37%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
-30.05%vs Pharmaceutical Retailers peers
Revenue (TTM)
1.18BCHF1.44B · vs all stocks (USD)
Revenue per Share (TTM)
24.49CHFUpdated Sep 23, 2026Quarterly Revenue Growth
14.90%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
261.25MCHF318.63M · vs all stocks (USD)
EBITDA (TTM)
-75.61MCHF-92.22M · vs all stocks (USD)
Net Income (TTM)
-125.94MCHF-153.61M · vs all stocks (USD)
Operating Cash Flow (TTM)
-54.03MCHF-65.90M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-51.90MCHF-63.31M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00CHFUpdated Sep 23, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Pharmaceutical Retailers peers
Revenue
1.02BCHFFY2024 · Dec 31, 2024Cost of Goods Sold
800.50MCHFFY2024 · Dec 31, 2024Gross Profit
216.54MCHFFY2024 · Dec 31, 2024Operating Income
-104.22MCHF-127.12M · vs all stocks (USD)
Pre-tax Income
-102.76MCHFFY2024 · Dec 31, 2024Income Tax Expense
-5.50MCHFFY2024 · Dec 31, 2024Net Income
-97.25MCHFFY2024 · Dec 31, 2024EBIT
-83.22MCHFFY2024 · Dec 31, 2024EBITDA (Income Statement)
-51.41MCHFFY2024 · Dec 31, 2024Selling, General & Administrative
158.47MCHFFY2024 · Dec 31, 2024Other Operating Expenses
17.89MCHFFY2024 · Dec 31, 2024Non-operating Interest Income
2.38MCHFFY2024 · Dec 31, 2024Non-operating Interest Expense
19.54MCHFFY2024 · Dec 31, 2024EPS (Basic)
-4.06CHFFY2024 · Dec 31, 2024EPS (Diluted)
-4.06CHFFY2024 · Dec 31, 2024Basic Shares Outstanding
23.95MSharesFY2024 · Dec 31, 2024Diluted Shares Outstanding
23.95MSharesFY2024 · Dec 31, 2024Net Income from Continuing Operations
-97.25MCHFFY2024 · Dec 31, 2024Preferred Stock Dividends
0.00CHFFY2024 · Dec 31, 2024Operating Cash Flow
-78.64MCHFFY2024 · Dec 31, 2024Free Cash Flow
-103.03MCHFFY2024 · Dec 31, 2024Cash & Cash Equivalents (End of Period)
95.37MCHFFY2024 · Dec 31, 2024Starting Profit (CF Statement)
-97.25MCHFFY2024 · Dec 31, 2024Other Non-cash Items
2.03MCHFFY2024 · Dec 31, 2024Change in Accounts Receivable (CF)
1.07MCHFFY2024 · Dec 31, 2024Change in Other Assets/Liabilities
15.52MCHFFY2024 · Dec 31, 2024Capital Expenditures
24.40MCHFFY2024 · Dec 31, 2024Net Intangibles (CF)
-27.25MCHFFY2024 · Dec 31, 2024Net Acquisitions
47.00MCHFFY2024 · Dec 31, 2024Purchase of Investments
-90.40MCHFFY2024 · Dec 31, 2024Sale of Investments
140.01MCHFFY2024 · Dec 31, 2024Net Investing Cash Flow
121.01MCHFFY2024 · Dec 31, 2024Long-term Debt Issuance
195.23MCHFFY2024 · Dec 31, 2024Other Financing Charges
-220.88MCHFFY2024 · Dec 31, 2024Net Financing Cash Flow
-25.65MCHFFY2024 · Dec 31, 2024Shares Outstanding
48.99MSharesUpdated Sep 23, 2026Float Shares
35.61MSharesUpdated Sep 23, 2026% Held by Insiders
31.29%vs all stocks
% Held by Institutions
25.35%vs all stocks
Total Cash (MRQ)
99.20MCHF120.99M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.06CHFUpdated Sep 23, 2026Total Debt (MRQ)
265.68MCHF324.04M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.7423xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.88xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
7.41CHFUpdated Sep 23, 2026Total Assets
778.13MCHF949.06M · vs all stocks (USD)
Total Current Assets
213.57MCHFFY2024 · Dec 31, 2024Total Liabilities
438.02MCHFFY2024 · Dec 31, 2024Total Non-current Assets
564.57MCHFFY2024 · Dec 31, 2024Total Non-current Liabilities
321.54MCHFFY2024 · Dec 31, 2024Total Current Liabilities
116.48MCHFFY2024 · Dec 31, 2024Cash & Cash Equivalents
95.37MCHFFY2024 · Dec 31, 2024Accounts Receivable
54.01MCHFFY2024 · Dec 31, 2024Inventory
37.08MCHFFY2024 · Dec 31, 2024Accounts Payable
59.41MCHFFY2024 · Dec 31, 2024Short-term Debt
4.26MCHFFY2024 · Dec 31, 2024Long-term Debt
307.95MCHFFY2024 · Dec 31, 2024Common Stock (Book)
445.05MCHFFY2024 · Dec 31, 2024Retained Earnings
-596.93MCHFFY2024 · Dec 31, 2024Total Shareholders' Equity
340.11MCHF414.82M · vs all stocks (USD)
Treasury Stock
90.56MCHFFY2024 · Dec 31, 202452-Week Low
3.92CHFUpdated Sep 23, 202652-Week High
11.69CHFUpdated Sep 23, 202652-Week Change
94.96%vs all stocks
Beta
1.88xvs all stocks
50-Day MA
10.21CHFUpdated Sep 23, 2026200-Day MA
7.26CHFUpdated Sep 23, 2026Avg 10-Day Volume
637.44KSharesUpdated Sep 23, 2026Avg 30-Day Volume
470.71KSharesUpdated Sep 23, 2026Diluted EPS (TTM)
-2.46CHFUpdated Sep 23, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Liquidity Ratios Elevated
It can cover near-term bills from cash alone, not just from inventory.
Reads
How does this company use capital?
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Scale
Revenue is $1.44B, above the global median of $558.46MNotable
Revenue (USD): 1,441,852,780.16Global Median: 558,459,881.051
Companies that share the same coordination system — how they create, deliver, or capture value.
Dogus Otomotiv Servis ve Ticaret A.S.
Tier 1FlowUnit ReplicationInterfaceRisk
Carrefoursa Carrefour Sabanci Ticaret Merkezi A.S.
Tier 1FlowUnit ReplicationInterfaceProduction
Shanghai Laiyifen Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
WH Smith plc
Tier 1FlowUnit ReplicationAttentionInterface
União Pet Participações S.A.
Tier 1FlowUnit ReplicationInterfaceProduction
Shuyu Civilian Pharmacy Co. Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Cass Information Systems, Inc.
Tier 1FlowUnit ReplicationProductionSenseMaking
Natural Grocers by Vitamin Cottage, Inc.
Tier 1FlowUnit ReplicationInterfaceAttention
Inner Mongolia Xinhua Distribution Group Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceAttention
Luyan Pharma Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Novoprotein Scientific Co., Ltd.
1 interpretationLiquidity Ratios Elevated
Scorpio Tankers Inc.
2 interpretationsLiquidity Ratios ElevatedThree Turnover Ratios Elevated
Gamestop Corp.
2 interpretationsLiquidity Ratios ElevatedThree Turnover Ratios Elevated